You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 7, July 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (57)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Complications of Denver Peritoneovenous Shunting

Robert H. Lund, MD; Mark W. Moritz, MD

Arch Surg. 1982;117(7):924-928.


Abstract

• The records of 49 consecutive patients treated with Denver peritoneovenous shunts were reviewed to determine the incidence of complications and length of patient survival. Thirty-eight complications (16 types) were identified in 22 (45%) of the patients and, in 10 instances, contributed to subsequent death. Ten percent of shunts failed during long-term follow-up. The 54% one-year survival by life-table analysis of patients with cirrhosis treated with the Denver shunt matched results previously reported for similar patients treated with the LeVeen shunt. Patients with intra-abdominal malignant neoplasms had an 11% one-year survival overall. Although it too is associated with significant complications, the Denver peritoneovenous shunt seems to have a lower failure rate and a lower incidence of complications than the LeVeen peritoneovenous shunt. Thus, the Denver shunt offers advantages in the treatment of intractable ascites.

(Arch Surg 1982;117:924-928)



Author Affiliations

From the Department of Surgery, Washington University School of Medicine, St Louis.


Footnotes

Accepted for publication Sept 24, 1981.

Reprint requests to Department of Surgery, Washington University School of Medicine, 4960 Audubon Ave, St Louis, MO 63110 (Dr Lund).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Solid intracardiac mass complicating peritoneovenous shunting
Jurmann et al.
ICVTS 2006;5:660-661.
ABSTRACT | FULL TEXT  

Peritoneovenous shunting is an effective treatment for intractable ascites
Sooriakumaran et al.
Postgrad. Med. J. 2005;81:259-261.
ABSTRACT | FULL TEXT  

Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter
Iyengar and Herzog
AM J HOSP PALLIAT CARE 2002;19:35-38.
ABSTRACT  

LeVeen vs Denver Peritoneovenous Shunts for Intractable Ascites of Cirrhosis: A Randomized, Prospective Trial
Fulenwider et al.
Arch Surg 1986;121:351-355.
ABSTRACT  

Peritoneovenous Shunts: Lessons Learned From an Eight-Year Experience With 70 Patients
Fulenwider et al.
Arch Surg 1984;119:1133-1137.
ABSTRACT  

Central Venous Thrombosis and Embolism Associated With Peritoneovenous Shunts
Foley et al.
Arch Surg 1984;119:713-720.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.